For most pregnant women, the thought of contracting an infection during pregnancy evokes fear—not just for their own health, but for the safety of their unborn child. Yet for some, the reality of congenital cytomegalovirus (CMV) infection reveals a harsh truth: the virus, which is harmless to 90% of adults, can cause severe disabilities in infants when transmitted vertically. Recent cases, including those of women like Carola (whose story was shared in Dutch media), highlight a critical gap in public awareness: CMV transmission during pregnancy is often unavoidable, and blaming mothers for their babies’ health outcomes is both scientifically inaccurate and emotionally damaging.

CMV, a member of the herpesvirus family, is ubiquitous. By age 40, roughly 50–80% of adults worldwide carry the virus, though most never experience symptoms. When a pregnant woman contracts CMV for the first time, there’s a 1–3% risk of transmitting it to her fetus, potentially leading to hearing loss, vision impairment, intellectual disabilities, or even stillbirth. The stigma surrounding congenital CMV—often framed as a “preventable” condition—ignores the virus’s stealthy nature and the lack of widespread screening or vaccination.

This article explores the science behind congenital CMV, why transmission during pregnancy is frequently beyond a mother’s control, and how healthcare systems can better support affected families. We also address the emotional toll of diagnosis and why public health messaging must shift from blame to prevention.

How Does CMV Spread During Pregnancy—and Why Is It So Hard to Avoid?

CMV spreads through bodily fluids, including saliva, urine, breast milk, and blood. Unlike viruses like rubella or toxoplasmosis, which require direct contact with infected animals or contaminated food, CMV can be transmitted through casual contact—such as kissing a toddler, changing a diaper, or sharing utensils with an infected child or adult

.

Here’s the critical detail often overlooked: most CMV transmissions during pregnancy occur from partners or other household members, not from the mother’s own behaviors. A study published in The Journal of Infectious Diseases found that primary CMV infection in pregnant women is most commonly acquired from sexual partners, while children under 3 years old are the primary source of transmission in non-pregnant adults. So that even meticulous hygiene—such as washing hands after diaper changes—may not prevent infection if a partner or child is asymptomatic carriers.

Adding to the challenge, CMV can remain dormant in the body and reactivate years later. A pregnant woman who was infected as a child may unknowingly shed the virus again, posing no risk to her fetus. Conversely, a woman acquiring CMV for the first time during pregnancy faces the highest transmission risk to her baby.

Debunking the Myth: “Could This Have Been Prevented?”

Stories like Carola’s—where a woman contracts CMV during pregnancy and later learns her baby may have congenital disabilities—often spark questions: Did she eat raw meat? Did she neglect hygiene? Could she have avoided this? The answer, according to infectious disease experts, is almost always no.

Dr. Mark Schleiss, a pediatric infectious disease specialist at the University of Minnesota, emphasizes that “CMV is not a virus you ‘catch’ like the flu or a cold. It’s a silent infection, and the idea that mothers could have prevented it is a misunderstanding of how the virus spreads”. There is no vaccine for CMV (though research is ongoing), and routine prenatal screening is not standard in most countries, including the U.S. And Europe.

This lack of screening contributes to the stigma. A 2023 survey by the CMV Action Foundation revealed that 78% of mothers with CMV-affected children reported feeling judged by healthcare providers or family members. The message these women hear—“You should have known better”—is not only unfair but also counterproductive to public health.

What Are the Risks to the Baby—and How Is It Diagnosed?

When CMV is transmitted during pregnancy, the severity of symptoms in the newborn varies widely. According to the U.S. Centers for Disease Control and Prevention (CDC), congenital CMV can cause:

• Hearing loss (the most common long-term effect, affecting up to 40% of infants with congenital CMV)
• Vision problems, including microphthalmia (compact eyes) or chorioretinitis (inflammation of the retina)
• Developmental delays, including intellectual disabilities or cerebral palsy
• Liver or spleen enlargement, jaundice, or seizures in severe cases

Diagnosis typically involves:

• Prenatal testing: Amniocentesis or fetal blood sampling can detect CMV in the amniotic fluid, but these are invasive and not routinely offered.
• Newborn screening: A hearing test within the first month of life is critical, as hearing loss may be progressive. The CDC recommends universal CMV screening for all newborns, but only a handful of U.S. States mandate it.
• Long-term monitoring: Children with congenital CMV may require regular audiological and ophthalmological evaluations.

Despite these tools, many cases go undetected. A 2022 study in The Lancet estimated that congenital CMV affects nearly 1% of all live births globally, yet fewer than 10% of infants receive a diagnosis before age 2.

Why Public Health Messaging Must Change

The framing of congenital CMV as a “preventable” condition is not only scientifically inaccurate but also harmful. It shifts blame onto mothers while ignoring systemic failures:

• No vaccine exists. Unlike rubella or varicella, there is no pre-pregnancy vaccine to prevent CMV.
• Screening is inconsistent. The World Health Organization (WHO) recommends CMV screening for high-risk populations, but implementation varies widely.
• Transmission is often unavoidable. As noted earlier, partners and young children are the primary sources of infection.

Dr. Paul Griffin, a virologist at the University of Leeds, argues that public health campaigns should focus on education—not guilt. “We tell women to avoid raw meat to prevent toxoplasmosis, but we don’t tell them to avoid kissing their toddlers,” he says. “CMV is part of everyday life, and the onus should be on raising awareness about transmission risks, not shaming mothers.”

Some countries are taking steps to address this. In 2023, the UK became the first nation to introduce universal newborn CMV hearing screening, following advocacy by organizations like the CMV Action Foundation. Meanwhile, researchers at the University of Alabama at Birmingham are testing a CMV vaccine candidate in clinical trials, offering hope for future prevention.

Support for Affected Families: What Comes Next?

For families like Carola’s, the journey after a congenital CMV diagnosis is complex. Here’s what to know:

• Early intervention is key. Physical therapy, hearing aids, and educational support can mitigate long-term effects.
• Financial and emotional support varies by country. In the U.S., organizations like the CMV Action Foundation provide resources, while some European countries offer disability benefits for affected children.
• Support groups exist. Connecting with other parents of CMV-affected children can reduce isolation. The CMV Support Network offers peer mentorship.

Carola’s refusal to feel guilty reflects a broader truth: congenital CMV is not a personal failure. It is a public health challenge that requires better screening, research, and compassionate messaging. As Dr. Schleiss puts it, “The virus doesn’t discriminate, and neither should our response to it.”

What’s Next for CMV Research and Policy?

The next critical milestones include:

• Vaccine development: The UAB CMV vaccine trial (expected to conclude in 2025) could lead to the first preventive measure.
• Expanded screening: Advocacy groups are pushing for universal newborn hearing tests in more countries.
• Global guidelines: The WHO is reviewing recommendations for CMV prevention in pregnancy.

In the meantime, pregnant women and their partners can reduce (though not eliminate) risk by:

• Avoiding contact with saliva or urine from young children (e.g., not sharing cups or toothbrushes).
• Washing hands thoroughly after diaper changes or caring for someone with CMV.
• Discussing CMV risks with healthcare providers, especially if exposed to young children or partners with unknown CMV status.

For those already affected, resources like the CMV Action Foundation’s toolkit and CDC’s parent guides offer practical support.

Have you or someone you know been affected by congenital CMV? Share your story or questions in the comments below—your insights may help others navigate this complex issue. For urgent medical advice, consult your healthcare provider or a specialist in maternal-fetal medicine.

For updates on CMV research and policy, follow World Today Journal’s Health section or subscribe to our newsletter.